These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25418505)

  • 1. Training improves oxidative capacity, but not function, in spinal muscular atrophy type III.
    Madsen KL; Hansen RS; Preisler N; Thøgersen F; Berthelsen MP; Vissing J
    Muscle Nerve; 2015 Aug; 52(2):240-4. PubMed ID: 25418505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study.
    Werlauff U; Vissing J; Steffensen BF
    Neuromuscul Disord; 2012 Dec; 22(12):1069-74. PubMed ID: 23127961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III.
    Kroksmark AK; Beckung E; Tulinius M
    Eur J Paediatr Neurol; 2001; 5(5):191-8. PubMed ID: 11585107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease).
    Preisler N; Andersen G; Thøgersen F; Crone C; Jeppesen TD; Wibrand F; Vissing J
    Neurology; 2009 Jan; 72(4):317-23. PubMed ID: 19171827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic capacity and muscle strength in juvenile-onset mixed connective tissue disease (MCTD).
    van der Net J; Wissink B; van Royen A; Helders PJ; Takken T
    Scand J Rheumatol; 2010; 39(5):387-92. PubMed ID: 20604672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical presentations of spinal muscular atrophy type III (Kugelberg-Welander disease).
    Kang PB; Krishnamoorthy KS; Jones RM; Shapiro FD; Darras BT
    Neuromuscul Disord; 2006 Aug; 16(8):492-4. PubMed ID: 16797181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leg muscle function and fatigue during walking in spinal muscular atrophy type 3.
    Montes J; Dunaway S; Garber CE; Chiriboga CA; De Vivo DC; Rao AK
    Muscle Nerve; 2014 Jul; 50(1):34-9. PubMed ID: 24122959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report.
    Dunaway S; Montes J; Ryan PA; Montgomery M; Sproule DM; De Vivo DC
    J Child Neurol; 2012 Jun; 27(6):779-85. PubMed ID: 22156787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle fatigue in spinal muscular atrophy.
    Iannaccone ST; White M; Browne R; Russman B; Buncher R; Samaha FJ
    J Child Neurol; 1997 Aug; 12(5):321-6. PubMed ID: 9378900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is acute static stretching able to reduce the time to exhaustion at power output corresponding to maximal oxygen uptake?
    Samogin Lopes FA; Menegon EM; Franchini E; Tricoli V; de M Bertuzzi RC
    J Strength Cond Res; 2010 Jun; 24(6):1650-6. PubMed ID: 20508470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
    Stam M; Wadman RI; Wijngaarde CA; Bartels B; Asselman FL; Otto LAM; Goedee HS; Habets LE; de Groot JF; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    BMJ Open; 2018 Jul; 8(7):e019932. PubMed ID: 30061431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
    Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
    Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical and genetic study of spinal muscular atrophy.
    Mishra VN; Kalita J; Kesari A; Mitta B; Shankar SK; Misra UK
    Electromyogr Clin Neurophysiol; 2004; 44(5):307-12. PubMed ID: 15378871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a low-intensity dynamic-resistance training protocol using an isokinetic dynamometer on muscular strength and aerobic capacity after coronary artery bypass grafting.
    Ghroubi S; Elleuch W; Abid L; Abdenadher M; Kammoun S; Elleuch MH
    Ann Phys Rehabil Med; 2013 Mar; 56(2):85-101. PubMed ID: 23414745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body vibration training in children with Duchenne muscular dystrophy and spinal muscular atrophy.
    Vry J; Schubert IJ; Semler O; Haug V; Schönau E; Kirschner J
    Eur J Paediatr Neurol; 2014 Mar; 18(2):140-9. PubMed ID: 24157400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerobic training in persons who have recovered from juvenile dermatomyositis.
    Riisager M; Mathiesen PR; Vissing J; Preisler N; Ørngreen MC
    Neuromuscul Disord; 2013 Dec; 23(12):962-8. PubMed ID: 24120572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy.
    Montes J; Goodwin AM; McDermott MP; Uher D; Hernandez FM; Coutts K; Cocchi J; Hauschildt M; Cornett KM; Rao AK; Monani UR; Ewing Garber C; De Vivo DC
    Ann Clin Transl Neurol; 2021 May; 8(5):1086-1095. PubMed ID: 33788421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.